119 related articles for article (PubMed ID: 70771)
21. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
[TBL] [Abstract][Full Text] [Related]
22. [Electrophoretic mobility test in the early diagnosis of malignant tumors; findings in the prestages of cervical and breast cancers].
Tautz C; Bögelspacher HR; Klaissle K
Onkologie; 1979 Oct; 2(5):199-203. PubMed ID: 94155
[TBL] [Abstract][Full Text] [Related]
23. [Dependence of leukocyte migration inhibition on the progress and activity of gynecological tumours (author's transl)].
Tosner J; Fixa B
Cesk Gynekol; 1979 Sep; 44(8):587-91. PubMed ID: 498305
[No Abstract] [Full Text] [Related]
24. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
Shenton BK; Jenssen HL; Werner H; Field EJ
J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
[TBL] [Abstract][Full Text] [Related]
25. Electrophoretic mobility test (EMT): studies on lymphocyte response and mechanism of the test using a rat tumor model.
Harthus HP; Ax W
Immunobiology; 1981; 158(3):151-72. PubMed ID: 6163695
[TBL] [Abstract][Full Text] [Related]
26. [Electrophoresis mobility test for early immunologic diagnosis of malignant gynecologic tumors].
Kreienberg R; Schütz G; Melchert F; Lemmel EM
Arch Gynecol; 1979 Jul; 228(1-4):605-6. PubMed ID: 485502
[No Abstract] [Full Text] [Related]
27. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
Cerni CH; Micksche M
Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
[TBL] [Abstract][Full Text] [Related]
28. Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.
Flavell DJ; Potter CW
Br J Cancer; 1978 Jan; 37(1):15-22. PubMed ID: 74259
[TBL] [Abstract][Full Text] [Related]
29. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
30. [The electrophoretic mobility test in cancer diagnosis at the 1st Women's Clinic of Vienna University].
Wagner G; Winter G
Onkologie; 1981 Feb; 4(1):34-8. PubMed ID: 7012732
[TBL] [Abstract][Full Text] [Related]
31. Cellular sensitization in tumor-bearing mice to soluble extracts from normal and malignant tissues. I. Common and individually distinct antigens as detected by electrophoretic mobility (EM) test.
Werner H; Jenssen HL; Köhler H; von Broen B; Pasternak G; Thuy LT; Schlott B; Pasternak L
Eur J Cancer (1965); 1978 May; 14(5):485-90. PubMed ID: 77224
[No Abstract] [Full Text] [Related]
32. Effect of lymphocyte supernatants on the electrophoretic mobility of erythrocytes: significance in cancer diagnosis.
Dyson JE; Corbett PJ
Br J Cancer; 1978 Sep; 38(3):401-10. PubMed ID: 708571
[TBL] [Abstract][Full Text] [Related]
33. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
Rahi AH; Otiko G; Winder AF
Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
[TBL] [Abstract][Full Text] [Related]
35. Emergence of new antigens in ageing tissues.
Field EJ; Shenton BK
Gerontologia; 1973; 19(4):211-9. PubMed ID: 4129994
[No Abstract] [Full Text] [Related]
36. Recent results of early detection of gynecological cancer in the German Democratic Republic.
Ebeling K
Arch Geschwulstforsch; 1980; 50(6):525-33. PubMed ID: 7224807
[TBL] [Abstract][Full Text] [Related]
37. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.
Nakajima T; Chikamori M; Isojima K; Iwaguchi T
Gan; 1977 Aug; 68(4):449-57. PubMed ID: 80343
[No Abstract] [Full Text] [Related]
39. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
40. Carcinoembryonic antigen in patients with gynecologic malignancies.
DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
